Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

206.23
-2.1100-1.01%
Post-market: 206.500.2700+0.13%17:15 EDT
Volume:7.00M
Turnover:1.45B
Market Cap:364.49B
PE:87.39
High:210.43
Open:208.37
Low:204.30
Close:208.34
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.16
T/O Rate:0.40%
Dividend:6.65
Dividend Rate:3.22%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:6225.00%
ROA:9.81%
PB:-111.46
PE(LYR):87.39

Loading ...

IDEAYA Biosciences Names Dr. Theodora Ross Chief Development Officer

Reuters
·
Feb 23

AbbVie FY 2025 net revenues rise 8.6% to USD 61.16B

Reuters
·
Feb 21

AbbVie Expands IPF Pipeline With New Phase 2a Study of ABBV-142

TIPRANKS
·
Feb 21

AbbVie Initiated at Overweight by Barclays

Dow Jones
·
Feb 20

FDA approves AbbVie venclexta, acalabrutinib supplemental new drug application

TIPRANKS
·
Feb 20

FDA approves AbbVie Venclexta and acalabrutinib combo for previously untreated CLL patients

Reuters
·
Feb 20

Daiwa Securities Raises AbbVie Price Target to $244 From $226, Maintains Outperform Rating

MT Newswires Live
·
Feb 20

AbbVie Keeps Quarterly Dividend at $1.73 a Share, Payable May 15 to Shareholders of Record on April 15

MT Newswires Live
·
Feb 19

Press Release: AbbVie Declares Quarterly Dividend

Dow Jones
·
Feb 19

AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 19

AbbVie’s ABBV-547 First‑in‑Human Trial: What Early Pipeline Moves Mean for ABBV Investors

TIPRANKS
·
Feb 19

AbbVie’s VOLITE Skin Quality Trial Completion: What It Means for ABBV Investors

TIPRANKS
·
Feb 19

Tarsus Pharmaceuticals Names Former Allergan CEO David Pyott to Board

Reuters
·
Feb 18

AbbVie Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 18

BRIEF-Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell

Reuters
·
Feb 18

HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating

MT Newswires Live
·
Feb 17

AbbVie Advances New Toxin-Based Therapy in Ventral Hernia Trial: What Investors Should Watch

TIPRANKS
·
Feb 14

Nxera Pharma Unveils Corporate Presentation Highlighting Global Strategy and Drug Discovery Platform

Reuters
·
Feb 13

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 13

AbbVie’s Korean Rinvoq Study Wraps Up, Bolstering Real-World Data for Immunology Growth

TIPRANKS
·
Feb 13